EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

The Value of Progression-Free Survival in the Perspective of Patients with Multiple Myeloma and Treating Physicians: Research Findings from the US, EU4, UK, Brazil, and Japan

Aaron S Rosenberg, Thomas Chalopin, Alison Bulkley, Kyla Finlayson, Corey Neff, Oliver Will, Yu-Hsuan Shih, Laurie Eliason, Thomas S Marshall, Zander Pittman, Marc DeCongelio

Clinical Lymphoma Myeloma and Leukemia · 2026-07 · 26 (7) · e829-e840.e3

DOI: 10.1016/j.clml.2026.03.018 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-07. Verfasst von Aaron S Rosenberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: UC Davis Comprehensive Cancer Center, Division of Malignant Hematology, Cellular Therapy & Transplantation, Sacramento, CA. Hauptthemen laut MEDLINE: Multiple Myeloma, Physicians. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bristol-Myers Squibb Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaPhysiciansHumansFemaleMaleJapanBrazilMiddle AgedCross-Sectional StudiesProgression-Free SurvivalAgedAdultUnited StatesUnited Kingdom

Stichwörter der Autor:innen

Multiple myelomaObservational studyOverall survivalPatient and physician perspectivesPrimary endpointProgression-free survivalQuestionnaire

Autor:innen und Institutionen

  • UC Davis Comprehensive Cancer Center, Division of Malignant Hematology, Cellular Therapy & Transplantation, Sacramento, CA.
  • Centre Hospitalier Universitaire de Tours, Tours, France.
  • Oracle Life Sciences, Austin, TX.
  • Bristol Myers Squibb, Princeton, NJ. Electronic address: aria.shih@bms.com.
  • Bristol Myers Squibb, Princeton, NJ.

Förderung

  • Bristol-Myers Squibb Company

Zitieren

APA

Rosenberg, A. S., Chalopin, T., Bulkley, A., Finlayson, K., Neff, C., Will, O., Shih, Y. H., Eliason, L., Marshall, T. S., Pittman, Z., & DeCongelio, M. (2026). The Value of Progression-Free Survival in the Perspective of Patients with Multiple Myeloma and Treating Physicians: Research Findings from the US, EU4, UK, Brazil, and Japan. Clinical Lymphoma Myeloma and Leukemia, 26(7), e829-e840.e3. https://doi.org/10.1016/j.clml.2026.03.018

Vancouver

Rosenberg AS, Chalopin T, Bulkley A, Finlayson K, Neff C, Will O, et al. The Value of Progression-Free Survival in the Perspective of Patients with Multiple Myeloma and Treating Physicians: Research Findings from the US, EU4, UK, Brazil, and Japan. Clinical Lymphoma Myeloma and Leukemia. 2026;26(7):e829-e840.e3. doi:10.1016/j.clml.2026.03.018

BibTeX
@article{Rosenberg2026,
  author = {Rosenberg, Aaron S and Chalopin, Thomas and Bulkley, Alison and Finlayson, Kyla and Neff, Corey and Will, Oliver and Shih, Yu-Hsuan and Eliason, Laurie and Marshall, Thomas S and Pittman, Zander and DeCongelio, Marc},
  title = {The Value of Progression-Free Survival in the Perspective of Patients with Multiple Myeloma and Treating Physicians: Research Findings from the US, EU4, UK, Brazil, and Japan},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  volume = {26},
  number = {7},
  pages = {e829--e840.e3},
  doi = {10.1016/j.clml.2026.03.018}
}
Kostenlos starten →